Conatus Pharmaceuticals' Series B - II Round

Conatus Pharmaceuticals raised a round of funding on April 13, 2011. Investors include MPM Capital.

Conatus Pharmaceuticals, a privately-held biotechnology company, is engaged in the development of human therapeutics to treat liver disease. Conatus is developing its lead compound, emricasan, for the…

Articles about Conatus Pharmaceuticals' Series B - II Round: